Surgical Resection Following Interleukin 2 Therapy for Metastatic Renal Cell Carcinoma Prolongs Remission
- 1 November 1992
- journal article
- clinical trial
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 127 (11) , 1343-1349
- https://doi.org/10.1001/archsurg.1992.01420110091018
Abstract
Research from JAMA Surgery — Surgical Resection Following Interleukin 2 Therapy for Metastatic Renal Cell Carcinoma Prolongs RemissionKeywords
This publication has 11 references indexed in Scilit:
- Nephrectomy in metastatic renal cell carcinomaCurrent Treatment Options in Oncology, 2003
- Interleukin-2 Immunotherapy Followed by Resection of Residual Renal Cell CarcinomaJournal of Urology, 1991
- Unexplained Spontaneous Regression and Alpha‐interferon as Treatment for Metastatic Renal CarcinomaBritish Journal of Urology, 1989
- Selection of initial therapy for renal cell carcinomaCancer, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Renal cell carcinoma: Survival and prognostic factorsUrology, 1986
- Solitary Metastasis from Renal Cell CarcinomaJournal of Urology, 1975
- Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal CancerBritish Journal of Cancer, 1971
- Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 casesCancer, 1971
- Surgery for Metastatic Renal Cell CarcinomaJournal of Urology, 1967